Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer
Cancer Treatment Reviews · 2025-01 · 132 · 102860
DOI: 10.1016/j.ctrv.2024.102860 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2025-01. Verfasst von Volkmar Müller und 12 weiteren Autor:innen. Beteiligte Einrichtung: The University Hospital, Martini Street 52, 20251, Hamburg, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms, Erb-b2 Receptor Tyrosine Kinases, Consensus. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Patients with HER2-positive breast cancer have a significant risk of developing brain metastases (BrM), which have detrimental effects on survival outcomes and quality of life. Although there are several systemic treatment options available that may delay the appearance of BrM and secondary progression of previously treated BrM, there are still substantial unmet needs for this patient population and primary prevention remains elusive. METHODS: A group of experts created consensus statements, through a modified Delphi process, to bridge the gap between current unmet needs, available evidence, and international guidelines. RESULTS: The steering committee reviewed all relevant literature and formed research questions to be answered by the subsequent consensus statements. In total, 61 contributors provided feedback on the consensus statements, with 34 statements reaching agreement out of the 55 statements that were voted on altogether. Statements with consensus aimed to define BrM primary and secondary prevention, screening procedures, assessment of symptoms, treatment efficacy, and preventing the occurrence and progression of BrM, while acknowledging the possibilities and limitations in daily clinical practice. Some statements did not reach agreement for a variety of reasons, mostly due to lack of evidence. CONCLUSIONS: The consensus statements outlined in this publication provide a point of reference for daily clinical practice and can act as recommendations for clinical trial procedures and future guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University Hospital, Martini Street 52, 20251, Hamburg, Germany.
- Centre Leon Berard, 28 Laennec Street, 69008, Lyon, France.
- Department of Oncology and Hemato-oncology, University of Milan, Festa del Perdono Street, 7 - 20122, Milan, Italy; Division of Early Drug Development, European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 2…
- Institut Jules Bordet, l'Université Libre de Bruxelles (U.L.B), Hôpital Universitaire de Bruxelles (HUB), Avenue Franklin Roosevelt 50, 1050, Brussels, Belgium.
- Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, 3500 Krems, Austria.
- Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Martini Street 52, 20251, Hamburg, Germany.
Zitieren
APA
Müller, V., Bachelot, T., Curigliano, G., de Azambuja, E., Furtner, J., Gempt, J., Jereczek-Fossa, B. A., Jerzak, K. J., Rhun, E. L., Palmieri, C., Pravettoni, G., Saura, C., & Bartsch, R. (2025). Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer. Cancer Treatment Reviews, 132, 102860. https://doi.org/10.1016/j.ctrv.2024.102860
Vancouver
Müller V, Bachelot T, Curigliano G, de Azambuja E, Furtner J, Gempt J, et al. Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer. Cancer Treatment Reviews. 2025;132:102860. doi:10.1016/j.ctrv.2024.102860
BibTeX
@article{Mller2025,
author = {Müller, Volkmar and Bachelot, Thomas and Curigliano, Giuseppe and de Azambuja, Evandro and Furtner, Julia and Gempt, Jens and Jereczek-Fossa, Barbara Alicja and Jerzak, Katarzyna J and Rhun, Emilie Le and Palmieri, Carlo and Pravettoni, Gabriella and Saura, Cristina and Bartsch, Rupert},
title = {Expert consensus on the prevention of brain metastases in patients with HER2-positive breast cancer},
journal = {Cancer Treatment Reviews},
year = {2025},
volume = {132},
pages = {102860},
doi = {10.1016/j.ctrv.2024.102860}
}
EUVIMED